Posts by Rod A. Rahimi, MD, PhD
-
Antibody Testing Vital to Managing the COVID-19 Pandemic
Massachusetts General Hospital clinicians believe serologic testing will be a critical tool in combating the COVID-19 pandemic.
-
Using Antibody Tests for COVID-19
Antibody testing holds promise as a method by which to identify the true past incidence or current prevalence of SARS-CoV-2 infection.
-
Neutralizing SARS-CoV-2-specific Antibodies and Virus-Specific T Cells Detected in People Recovering from COVID-19
Massachusetts General Hospital reserarchers discuss a new study that provides the most comprehensive evidence yet that people who recover from COVID-19 acquire protective immunity.
-
New Data on Protective Immunity After COVID-19
The world is eager for an “immunity test” for SARS-CoV-2, but the level and duration of protective immunity after recovery from COVID-19 remain to be defined.
-
Will Humans Develop Immunity After SARS-CoV-2 Infection?
Massachusetts General Hospital researchers believe that people will likely develop protective immunity after infection with the novel coronavirus, SARS-CoV-2, but immunity may wane over time.
-
The Antibody-dependent Enhancement Hypothesis in Severe COVID-19
Researchers have speculated that some cases of severe COVID-19 may be attributable to antibodies from prior coronavirus infections.
-
Protective Immunity to SARS-CoV-2
Evidence suggests that humans will develop protective immunity after infection with SARS-CoV-2, although immunity may wane with time.
-
Antibodies in Severe COVID-19
Many people are saying...severe COVID-19 is caused by the immune system. How could that be?
Pulmonary and Critical Care Medicine
The Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital provides comprehensive care for the full range of respiratory conditions and diseases.